JP

Active Director Director DIN 10075675
DIN 10075675 First appointment Mar 2023 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Jay Patel

Data last updated:

Jay Patel is a Director at Parisar Pharmaceuticals Private Limited (since 2023). The company operates in E-Commerce. Parisar Pharmaceuticals Private Limited reported revenue of ₹1.3 Lakh (FY 2024).

DIN 10075675
Primary Designation Director
Industry E-Commerce
First Appointment 16 Mar 2023
Oldest Company Age 3 yrs
Largest company Parisar Pharmaceuticals Private Limited · ₹1.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Mar 20232023₹1.3 Lakh (FY 2024)Active

Board colleagues of Jay Patel

NameDINCompanyDesignation
Yashvantkumar Patel10075674Parisar Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Parisar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jay Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jay Patel

Jay Patel currently holds 1 directorship: Parisar Pharmaceuticals Private Limited (Director, since 16 Mar 2023, revenue ₹1.3 Lakh (FY 2024)).

Jay Patel was first appointed on 16 Mar 2023 as Director at Parisar Pharmaceuticals Private Limited.

The current boards of Jay Patel's companies include Yashvantkumar Patel (Parisar Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available